Idarubicin hydrochloride is an active pharmaceutical ingredient used in the manufacturing of oncology-related pharmaceutical products. It is associated with potential developmental and male reproductive toxicity as indicated by regulatory labeling requirements.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 57852-57-0
Idarubicin
pharmaceutical raw material
Daunorubicin hydrochloride
pharmaceutical raw material
Sabarubicin
pharmaceutical raw material
Clozapine
second generation antipsychotic agent
N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanamide;hydrochloride
pharmaceutical raw material
Deacyl acebutolol
pharmaceutical raw material
Isoxsuprine hydrochloride
pharmaceutical raw material
Daunorubicin
pharmaceutical raw material
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
JVHPTYWUBOQMBP-RVFAQHLVSA-N
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl